Relationship of plasma interleukin-18 concentrations to traditional and non-traditional cardiovascular risk factors in patients with systemic lupus erythematosus

Tim K. Tso, Wen Nan Huang, Hui Yu Huang, Chen Kang Chang

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Objectives. Systemic lupus erythematosus (SLE) is associated with premature atherosclerosis. Recent studies indicated that the concentrations of circulating interleukin (IL)-18, a novel proinflammatory T helper-1 cytokine, in SLE patients were significantly higher than those in healthy control subjects. The objective of this study was to examine the relationship between IL-18 and cardiovascular risk factors in patients with SLE. Methods. Both traditional and non-traditional cardiovascular risk factors including body mass index (BMI), systolic blood pressure, diastolic blood pressure (DBP), fasting insulin and glucose, plasma lipid profile, plasma homocysteine, thiobarbituric acid-reactive substances, titres of autoantibodies against oxidized low-density lipoprotein, and brachial-ankle pulse wave velocity (baPWV) were determined in a total of 72 female SLE patients. All patients were further classified into subgroups based on tertiles of plasma IL-18 concentrations. Results. Plasma concentrations of IL-18 were significantly higher in SLE patients than age-matched healthy controls. SLE patients with IL-18 concentration in the top tertile compared with the bottom tertile had significantly higher plasma levels of insulin, triglyceride, homocysteine and values of homeostasis model assessment insulin resistance (HOMA IR) and HOMA β-cell. In addition, plasma concentrations of IL-18 correlated positively and significantly with BMI, insulin, HOMA IR, HOMA β-cell, triglyceride, homocysteine, DBP and baPWV in all SLE patients. Conclusions. This is the first report showing the relationship between IL-18 and cardiovascular risk factors in SLE. In patients with SLE, the synergistic effects of hyperinsulinaemia, insulin resistance, hyperhomocysteinaemia, and vascular stiffness most likely contribute to the elevation of plasma IL-18 concentrations.

Original languageEnglish
Pages (from-to)1148-1153
Number of pages6
JournalRheumatology
Volume45
Issue number9
DOIs
Publication statusPublished - Sep 1 2006
Externally publishedYes

Fingerprint

Interleukin-18
Systemic Lupus Erythematosus
Blood Pressure
Homocysteine
Insulin Resistance
Pulse Wave Analysis
Insulin
Ankle
Triglycerides
Body Mass Index
Arm
Homeostasis
Hyperhomocysteinemia
Vascular Stiffness
Thiobarbituric Acid Reactive Substances
Hyperinsulinism
Autoantibodies
Fasting
Atherosclerosis
Healthy Volunteers

Keywords

  • Brachial-ankle pulse wave velocity
  • Cardiovascular risk
  • Homocysteine
  • Insulin
  • Interleukin-18
  • Systemic lupus erythematosus

ASJC Scopus subject areas

  • Rheumatology
  • Pharmacology (medical)

Cite this

Relationship of plasma interleukin-18 concentrations to traditional and non-traditional cardiovascular risk factors in patients with systemic lupus erythematosus. / Tso, Tim K.; Huang, Wen Nan; Huang, Hui Yu; Chang, Chen Kang.

In: Rheumatology, Vol. 45, No. 9, 01.09.2006, p. 1148-1153.

Research output: Contribution to journalArticle

@article{145b61adb68c4894be826aee818a743b,
title = "Relationship of plasma interleukin-18 concentrations to traditional and non-traditional cardiovascular risk factors in patients with systemic lupus erythematosus",
abstract = "Objectives. Systemic lupus erythematosus (SLE) is associated with premature atherosclerosis. Recent studies indicated that the concentrations of circulating interleukin (IL)-18, a novel proinflammatory T helper-1 cytokine, in SLE patients were significantly higher than those in healthy control subjects. The objective of this study was to examine the relationship between IL-18 and cardiovascular risk factors in patients with SLE. Methods. Both traditional and non-traditional cardiovascular risk factors including body mass index (BMI), systolic blood pressure, diastolic blood pressure (DBP), fasting insulin and glucose, plasma lipid profile, plasma homocysteine, thiobarbituric acid-reactive substances, titres of autoantibodies against oxidized low-density lipoprotein, and brachial-ankle pulse wave velocity (baPWV) were determined in a total of 72 female SLE patients. All patients were further classified into subgroups based on tertiles of plasma IL-18 concentrations. Results. Plasma concentrations of IL-18 were significantly higher in SLE patients than age-matched healthy controls. SLE patients with IL-18 concentration in the top tertile compared with the bottom tertile had significantly higher plasma levels of insulin, triglyceride, homocysteine and values of homeostasis model assessment insulin resistance (HOMA IR) and HOMA β-cell. In addition, plasma concentrations of IL-18 correlated positively and significantly with BMI, insulin, HOMA IR, HOMA β-cell, triglyceride, homocysteine, DBP and baPWV in all SLE patients. Conclusions. This is the first report showing the relationship between IL-18 and cardiovascular risk factors in SLE. In patients with SLE, the synergistic effects of hyperinsulinaemia, insulin resistance, hyperhomocysteinaemia, and vascular stiffness most likely contribute to the elevation of plasma IL-18 concentrations.",
keywords = "Brachial-ankle pulse wave velocity, Cardiovascular risk, Homocysteine, Insulin, Interleukin-18, Systemic lupus erythematosus",
author = "Tso, {Tim K.} and Huang, {Wen Nan} and Huang, {Hui Yu} and Chang, {Chen Kang}",
year = "2006",
month = "9",
day = "1",
doi = "10.1093/rheumatology/kel082",
language = "English",
volume = "45",
pages = "1148--1153",
journal = "Rheumatology",
issn = "1462-0324",
publisher = "Oxford University Press",
number = "9",

}

TY - JOUR

T1 - Relationship of plasma interleukin-18 concentrations to traditional and non-traditional cardiovascular risk factors in patients with systemic lupus erythematosus

AU - Tso, Tim K.

AU - Huang, Wen Nan

AU - Huang, Hui Yu

AU - Chang, Chen Kang

PY - 2006/9/1

Y1 - 2006/9/1

N2 - Objectives. Systemic lupus erythematosus (SLE) is associated with premature atherosclerosis. Recent studies indicated that the concentrations of circulating interleukin (IL)-18, a novel proinflammatory T helper-1 cytokine, in SLE patients were significantly higher than those in healthy control subjects. The objective of this study was to examine the relationship between IL-18 and cardiovascular risk factors in patients with SLE. Methods. Both traditional and non-traditional cardiovascular risk factors including body mass index (BMI), systolic blood pressure, diastolic blood pressure (DBP), fasting insulin and glucose, plasma lipid profile, plasma homocysteine, thiobarbituric acid-reactive substances, titres of autoantibodies against oxidized low-density lipoprotein, and brachial-ankle pulse wave velocity (baPWV) were determined in a total of 72 female SLE patients. All patients were further classified into subgroups based on tertiles of plasma IL-18 concentrations. Results. Plasma concentrations of IL-18 were significantly higher in SLE patients than age-matched healthy controls. SLE patients with IL-18 concentration in the top tertile compared with the bottom tertile had significantly higher plasma levels of insulin, triglyceride, homocysteine and values of homeostasis model assessment insulin resistance (HOMA IR) and HOMA β-cell. In addition, plasma concentrations of IL-18 correlated positively and significantly with BMI, insulin, HOMA IR, HOMA β-cell, triglyceride, homocysteine, DBP and baPWV in all SLE patients. Conclusions. This is the first report showing the relationship between IL-18 and cardiovascular risk factors in SLE. In patients with SLE, the synergistic effects of hyperinsulinaemia, insulin resistance, hyperhomocysteinaemia, and vascular stiffness most likely contribute to the elevation of plasma IL-18 concentrations.

AB - Objectives. Systemic lupus erythematosus (SLE) is associated with premature atherosclerosis. Recent studies indicated that the concentrations of circulating interleukin (IL)-18, a novel proinflammatory T helper-1 cytokine, in SLE patients were significantly higher than those in healthy control subjects. The objective of this study was to examine the relationship between IL-18 and cardiovascular risk factors in patients with SLE. Methods. Both traditional and non-traditional cardiovascular risk factors including body mass index (BMI), systolic blood pressure, diastolic blood pressure (DBP), fasting insulin and glucose, plasma lipid profile, plasma homocysteine, thiobarbituric acid-reactive substances, titres of autoantibodies against oxidized low-density lipoprotein, and brachial-ankle pulse wave velocity (baPWV) were determined in a total of 72 female SLE patients. All patients were further classified into subgroups based on tertiles of plasma IL-18 concentrations. Results. Plasma concentrations of IL-18 were significantly higher in SLE patients than age-matched healthy controls. SLE patients with IL-18 concentration in the top tertile compared with the bottom tertile had significantly higher plasma levels of insulin, triglyceride, homocysteine and values of homeostasis model assessment insulin resistance (HOMA IR) and HOMA β-cell. In addition, plasma concentrations of IL-18 correlated positively and significantly with BMI, insulin, HOMA IR, HOMA β-cell, triglyceride, homocysteine, DBP and baPWV in all SLE patients. Conclusions. This is the first report showing the relationship between IL-18 and cardiovascular risk factors in SLE. In patients with SLE, the synergistic effects of hyperinsulinaemia, insulin resistance, hyperhomocysteinaemia, and vascular stiffness most likely contribute to the elevation of plasma IL-18 concentrations.

KW - Brachial-ankle pulse wave velocity

KW - Cardiovascular risk

KW - Homocysteine

KW - Insulin

KW - Interleukin-18

KW - Systemic lupus erythematosus

UR - http://www.scopus.com/inward/record.url?scp=33749597033&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749597033&partnerID=8YFLogxK

U2 - 10.1093/rheumatology/kel082

DO - 10.1093/rheumatology/kel082

M3 - Article

VL - 45

SP - 1148

EP - 1153

JO - Rheumatology

JF - Rheumatology

SN - 1462-0324

IS - 9

ER -